Press Release PetVivo Adds Two Independent Board Members
(All Press Releases Will Be Available for Viewing on Facebook or the Web at www.petvivo.com )
PetVivo Adds David Deming and Peter Vezmar as Independent Directors
PetVivo Holdings, Inc. (www.petvivo.com) is pleased to announce that David Deming and Peter Vezmar will join the PetVivo PetVivo Board of Directors as independent members.
Peter Vezmar is currently the President and CEO of Marula Enterprises, a holding company founded to pursue investment opportunities primarily focused on targeted middle-market companies. Peter has more than thirty-five years of diverse experience in business management and strategy, corporate finance, IPOs, mergers and acquisitions, financial reporting, regulatory compliance, tax matters and corporate governance. Including a wide range of experience and understanding in many industries, including options/futures, life sciences/biotech, IT technologies, insurance, recycling, transportation/logistics, advertising, renewable energy and micro-brewery, among others.
“I look forward to joining the PetVivo team and working hard to realize the potential value of its innovative technology for shareholders,” commented Peter Vezmar.
David Deming has over thirty years of experience in client service, sales, marketing, operations and compliance.
David currently is a Partner at Asymmetric Capital Management, LLC. and he also serves as the Acting CEO, Treasurer and a Director at Wildfire 5G, Inc. Asymmetric Capital Management provides investment management services and the company is a pioneer in the build out of Hedged Beta Indices. Wildfire, 5G designs, builds, maintains, and operates next generation protected internet wireless networks that deliver a host of high-speed internet and telecommunication services to residential, educational, medical, hospitality and enterprise industries.
“I am very excited to be joining the Petvivo Board as they are a leading-edge growth company. I look forward to working with their experienced, innovative senior management team,” stated David Deming.
“We are very pleased to have these two gentlemen join our Board of Directors. Both David and Peter have extensive experience operating and solving the problems that high growth businesses face. They add another level of expertise to our team,” noted Wes Hayne, the Company’s CEO.
About PetVivo Holdings, Inc.
PetVivo Holdings Inc. (OTCPINK: PETV) is an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets and pet therapeutics. PetVivo is leveraging investments made in the human medical device industry to commercialize therapeutics for pets in a capital and time efficient way. A key component of this strategy is the accelerated timeline to revenues for veterinary medical devices, which enter the market much earlier than the more stringently regulated pharmaceuticals.
PetVivo’s strategy is to commercialize proprietary products from human medical device companies specifically for the companion animal market. The company’s product pipeline includes seventeen animal and human therapeutics. A portfolio of twenty patents protects the company’s products, production processes and biomaterials. PetVivo’s lead product, a veterinarian-administered joint injection for the treatment of osteoarthritis in dogs, is scheduled for launch later this year.
The Company will also be seeking licensing partners to commercialize its portfolio of proprietary human clinical therapeutics in large market sectors, including: cardiovascular, orthopedic, urology and aesthetics.
Forward-Looking commercial Statements:
The foregoing material may contain forward-looking statements. We caution that such statements may be subject to uncertainties and that actual results could differ materially from the forward-looking statements. Readers accordingly should not place undue reliance on these forward-looking statements, which do not reflect unknown or unanticipated events or circumstances occurring after the date of these forward-looking statements.
PetVivo Holdings, Inc.
Main: (612) 296-7305
Direct: (763) 443-7272